RVTY vs WAT: stock comparison and AI forecast
Revvity, Inc. (RVTY) and Waters Corp /De/ (WAT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
RVTY Revvity, Inc.
- Price
- $155.11 +56.9% · 6M
- Market Cap
- $17.31B
- P/E Ratio
- 74.6x
- Size
- large-cap
- AI Forecast
WAT Waters Corp /De/
- Price
- $453.08 +29.3% · 6M
- Market Cap
- $44.51B
- P/E Ratio
- 93.0x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- WAT is 2.6 times larger than RVTY by market capitalization ($44.51B against $17.31B).
- RVTY trades at 74.6 times trailing earnings, WAT at 93.0 times.
- Over the last six months RVTY returned +56.9% and WAT +29.3%.
- RVTY carries 0.67 times debt per unit of equity, against 0.63 times for WAT.
- RVTY yields 0.18% in dividends; WAT pays none.
- Both companies share the SEC industry classification Laboratory Analytical Instruments.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | RVTY | WAT |
|---|---|---|
| Market Cap | $17.31B | $44.51B |
| P/E Ratio | 74.57x | 93.03x |
| P/B Ratio | 2.39x | 2.93x |
| Dividend Yield | 0.18% | – |
| EPS | $2.08 | $4.87 |
| Book Value/Share | $64.78 | $154.66 |
| Revenue/Share | $26.09 | $47.27 |
| FCF/Share | $5.00 | – |
Profitability & Margins
| Metric | RVTY | WAT |
|---|---|---|
| ROE | 3.3% | – |
| ROA | 2.0% | – |
| ROIC | 3.3% | 1.5% |
| Gross Margin | 55.8% | – |
| Operating Margin | 12.3% | 7.1% |
| Net Margin | 8.2% | – |
| EBT Margin | 9.0% | 4.4% |
| Tax Rate | 9.0% | 19.1% |
Financial Health
| Metric | RVTY | WAT |
|---|---|---|
| Current Ratio | 1.80x | 1.86x |
| Quick Ratio | 1.50x | 1.29x |
| D/E Ratio | 0.67x | 0.63x |
| Financial Leverage | 1.67x | 1.63x |
| Interest Coverage | 1.3x | – |
| Working Capital | $1.02B | $2.07B |
Cash Flow
| Metric | RVTY | WAT |
|---|---|---|
| Operating Cash Flow | $628M | $550M |
| Free Cash Flow | $558M | – |
| Capital Spending | -$70M | – |
| OCF Growth YoY | 7.4% | -26.2% |
| FCF Growth YoY | 11.0% | – |
| FCF/Sales | 19.2% | – |
| CapEx/Sales | 2.4% | – |
Operational Efficiency
| Metric | RVTY | WAT |
|---|---|---|
| Asset Turnover | 0.24x | 0.19x |
| Receivables Turnover | 4.1x | 2.3x |
| Inventory Turnover | 3.4x | – |
| Fixed Assets Turnover | 6.4x | 3.1x |
| Days Sales Outstanding | 89 days | 156 days |
| Days Inventory | 107 days | – |
| Payables Period | 47 days | – |
| Cash Conversion Cycle | 149 days | – |
Income Statement
| Metric | RVTY | WAT |
|---|---|---|
| Total Revenue | $2.91B | $4.64B |
| Operating Income | $359M | $330M |
| Net Income | $238M | – |
| R&D Expense | $216M | $319M |
| SG&A Expense | $1.03B | $1.25B |
| Cost of Goods Sold | $1.29B | – |
Dividend & Shareholder Information
| Metric | RVTY | WAT |
|---|---|---|
| Dividends Per Share | $0.28 | – |
| Payout Ratio | 13.5% | – |
| Shares Outstanding | 112M | 98M |
| Net Income Growth | -16.7% | – |
| EPS Growth | -5.9% | -56.1% |
RVTY vs WAT: stock comparison and AI forecast
Which is bigger, RVTY or WAT?
WAT is 2.6 times larger than RVTY by market capitalization ($44.51B against $17.31B).
Which is cheaper on earnings, RVTY or WAT?
RVTY trades at 74.6 times trailing earnings, WAT at 93.0 times.
Which stock performed better over the last six months, RVTY or WAT?
Over the last six months RVTY returned +56.9% and WAT +29.3%.
Which one does Intratio's AI model rank higher, RVTY or WAT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.